Literature DB >> 23600611

Short communication: prevalence of antibodies against Coxiella burnetii (Q fever) in children in The Gambia, West Africa.

Wim van der Hoek1, Ramu Sarge-Njie, Tineke Herremans, Thomas Chisnall, Joseph Okebe, Eniyou Oriero, Bart Versteeg, Bart Goossens, Marianne van der Sande, Beate Kampmann, Davis Nwakanma.   

Abstract

OBJECTIVE: To estimate the prevalence of antibodies against Coxiella burnetii (Q fever) among children in eight villages in The Gambia, West Africa.
METHODS: Sera of 796 children aged 1-15 years were tested for presence of antibodies against phase II of C. burnetii by ELISA.
RESULTS: IgG and/or IgM phase II antibodies against C. burnetii were detectable in 8.3% (66/796) of all serum samples analysed with significant differences in seroprevalence between villages. Highest prevalence was found in the age group 1-4 years.
CONCLUSIONS: Exposure to C. burnetii is considerable in the early years of life in The Gambia, and further studies are warranted to estimate the role of Q fever in acute febrile illness in The Gambia and elsewhere in Africa.
© 2013 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23600611     DOI: 10.1111/tmi.12116

Source DB:  PubMed          Journal:  Trop Med Int Health        ISSN: 1360-2276            Impact factor:   2.622


  8 in total

1.  Acute Q Fever Case Detection among Acute Febrile Illness Patients, Thailand, 2002-2005.

Authors:  Ashley L Greiner; Saithip Bhengsri; Matthieu Million; Sophie Edouard; Somsak Thamthitiwat; Kevin Clarke; Gilbert J Kersh; Christopher J Gregory; Didier Raoult; Philippe Parola
Journal:  Am J Trop Med Hyg       Date:  2018-01       Impact factor: 2.345

Review 2.  From Q Fever to Coxiella burnetii Infection: a Paradigm Change.

Authors:  Carole Eldin; Cléa Mélenotte; Oleg Mediannikov; Eric Ghigo; Matthieu Million; Sophie Edouard; Jean-Louis Mege; Max Maurin; Didier Raoult
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

3.  Febrile patients admitted to remote hospitals in Northeastern Kenya: seroprevalence, risk factors and a clinical prediction tool for Q-Fever.

Authors:  J Njeru; K Henning; M W Pletz; R Heller; C Forstner; S Kariuki; E M Fèvre; H Neubauer
Journal:  BMC Infect Dis       Date:  2016-06-03       Impact factor: 3.090

4.  Coxiella burnetii seroprevalence in small ruminants in The Gambia.

Authors:  Marieke Klaasen; Hendrik-Jan Roest; Wim van der Hoek; Bart Goossens; Arss Secka; Arjan Stegeman
Journal:  PLoS One       Date:  2014-01-15       Impact factor: 3.240

5.  The Sero-epidemiology of Coxiella burnetii in Humans and Cattle, Western Kenya: Evidence from a Cross-Sectional Study.

Authors:  Nicola A Wardrop; Lian F Thomas; Elizabeth A J Cook; William A de Glanville; Peter M Atkinson; Claire N Wamae; Eric M Fèvre
Journal:  PLoS Negl Trop Dis       Date:  2016-10-07

6.  Incidence Estimates of Acute Q Fever and Spotted Fever Group Rickettsioses, Kilimanjaro, Tanzania, from 2007 to 2008 and from 2012 to 2014.

Authors:  Sruti Pisharody; Matthew P Rubach; Manuela Carugati; William L Nicholson; Jamie L Perniciaro; Holly M Biggs; Michael J Maze; Julian T Hertz; Jo E B Halliday; Kathryn J Allan; Blandina T Mmbaga; Wilbrod Saganda; Bingileki F Lwezaula; Rudovick R Kazwala; Sarah Cleaveland; Venance P Maro; John A Crump
Journal:  Am J Trop Med Hyg       Date:  2021-12-20       Impact factor: 2.345

Review 7.  Epidemiology of Coxiella burnetii infection in Africa: a OneHealth systematic review.

Authors:  Sky Vanderburg; Matthew P Rubach; Jo E B Halliday; Sarah Cleaveland; Elizabeth A Reddy; John A Crump
Journal:  PLoS Negl Trop Dis       Date:  2014-04-10

8.  The Use of Guidelines for Lower Respiratory Tract Infections in Tanzania: A Lesson from Kilimanjaro Clinicians.

Authors:  B Mbwele; A Slot; Q De Mast; P Kweka; M Msuya; M Hulscher
Journal:  Ann Med Health Sci Res       Date:  2016 Mar-Apr
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.